{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:07:24Z","timestamp":1779930444155,"version":"3.53.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R349-2020-835"],"award-info":[{"award-number":["R349-2020-835"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"publisher","award":["KBVU-MS R327-A19137"],"award-info":[{"award-number":["KBVU-MS R327-A19137"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["0134-00257B"],"award-info":[{"award-number":["0134-00257B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005747","name":"A.P. M\u00f8ller og Hustru Chastine Mc-Kinney M\u00f8llers Fond til almene Formaal","doi-asserted-by":"publisher","award":["R320-A18526"],"award-info":[{"award-number":["R320-A18526"]}],"id":[{"id":"10.13039\/501100005747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.vaccine.2024.05.021","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T04:17:50Z","timestamp":1716524270000},"page":"125972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Changes in vaccination uptake against pneumococcal disease, influenza, and coronavirus disease 2019 (COVID-19) before and after a Head and Neck cancer diagnosis"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9395-7045","authenticated-orcid":false,"given":"Mads Frederik","family":"Eiberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2198-1904","authenticated-orcid":false,"given":"Omid","family":"Rezahosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine Brandt","family":"Bukan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodil","family":"Charlotte Arp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian Bui","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Howitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeppe","family":"Friborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte","family":"Lindegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zitta Barrella","family":"Harboe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.05.021_b0005","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/cid\/ciaa090","article-title":"Differences and temporal changes in risk of invasive pneumococcal disease in adults with hematological malignancies: results from a nationwide 16-year cohort study","volume":"72","author":"Andersen","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.021_b0010","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejca.2020.09.035","article-title":"Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)","volume":"141","author":"Li\u00e8vre","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.vaccine.2024.05.021_b0015","first-page":"618","article-title":"Epidemiology and Outcomes of Serious Influenza-Related Infections in the Cancer","author":"Cooksley","year":"2005","journal-title":"Population"},{"key":"10.1016\/j.vaccine.2024.05.021_b0020","doi-asserted-by":"crossref","unstructured":"Garcia HM, Knol MJ, Heijmans J, Sorge NM Van, Sanders EAM, Kl\u00fcmpen H, et al. International Journal of Infectious Diseases Invasive pneumococcal disease among adults with hematological and solid organ malignancies\u00a0: A population-based cohort study 2021;106:237\u201345.","DOI":"10.1016\/j.ijid.2021.03.072"},{"key":"10.1016\/j.vaccine.2024.05.021_b0025","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/jamaoncol.2020.0980","article-title":"SARS-CoV-2 Transmission in Patients with Cancer at a Tertiary Care Hospital in Wuhan, China","volume":"6","author":"Yu","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.vaccine.2024.05.021_b0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1200\/JOP.18.00567","article-title":"Epidemiology, diagnosis, treatment, and prevention of influenza infection in oncology patients","volume":"15","author":"El Ramahi","year":"2019","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.vaccine.2024.05.021_b0035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.medmal.2019.11.006","article-title":"Observational study of vaccination in cancer patients: How can vaccine coverage be improved?","volume":"50","author":"Monier","year":"2020","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.vaccine.2024.05.021_b0040","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1093\/infdis\/jiad174","article-title":"COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future","volume":"228","author":"Hall","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.021_b0045","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/cncr.28588","article-title":"Causes of death in long-term survivors of head and neck cancer","volume":"120","author":"Baxi","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.vaccine.2024.05.021_b0050","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1002\/cam4.5456","article-title":"Increased risk of death from pneumonia among cancer survivors: A propensity score-matched cohort analysis","volume":"12","author":"Tanaka","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.vaccine.2024.05.021_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2022.03.020","article-title":"Early non-cancer mortality risk prediction after curative-intent radiotherapy or chemoradiotherapy for head and neck squamous cell carcinoma","volume":"171","author":"Jensen","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.vaccine.2024.05.021_b0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/0194599820938011","article-title":"Factors Influencing the Development of Pneumonia in Patients With Head and Neck Cancer: A Meta-analysis","volume":"164","author":"Reddy","year":"2021","journal-title":"Otolaryngology - Head and Neck Surgery (United States)"},{"key":"10.1016\/j.vaccine.2024.05.021_b0065","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/hed.26217","article-title":"Respiratory and pulmonary complications in head and neck cancer patients: Evidence-based review for the COVID-19 era","volume":"42","author":"Silverman","year":"2020","journal-title":"Head Neck"},{"key":"10.1016\/j.vaccine.2024.05.021_b0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2024.05.021_b0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/5584_2016_193","article-title":"Influenza vaccination coverage among polish patients with chronic diseases","author":"Nitsch-Osuch","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2024.05.021_b0080","article-title":"Low influenza vaccination rate among cancer patients receiving chemotherapy for cancer.pdf","author":"Loulegru","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.vaccine.2024.05.021_b0085","first-page":"58","article-title":"IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"2014","author":"Rubin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.021_b0090","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s00520-015-3037-6","article-title":"Vaccination of chemotherapy patients\u2014effect of guideline implementation","volume":"24","author":"Toleman","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.vaccine.2024.05.021_b0095","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.vaccine.2015.02.029","article-title":"Influenza vaccination perception and coverage among patients with malignant disease","volume":"33","author":"Poeppl","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.021_b0100","doi-asserted-by":"crossref","unstructured":"Fu L, Wu S, Wang B, Zheng W, Sun Y, Tian T, et al. COVID-19 vaccination perception and uptake among cancer patients in Guangzhou, China. Hum Vaccin Immunother 2022;18. DOI: 10.1080\/21645515.2022.2102329.","DOI":"10.1080\/21645515.2022.2102329"},{"key":"10.1016\/j.vaccine.2024.05.021_b0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejca.2017.02.012","article-title":"Influenza vaccination in adult patients with solid tumours treated with chemotherapy","volume":"76","author":"Vollaard","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.vaccine.2024.05.021_b0110","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1016\/j.vaccine.2016.11.015","article-title":"Vaccination of special populations: Protecting the vulnerable","volume":"34","author":"Doherty","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.021_b0115","unstructured":"Pedersen AB, Johnsen SP. Vejledning for validering af data fra kliniske kvalitetsdatabaser Juni 2017 2017:1\u201319."},{"key":"10.1016\/j.vaccine.2024.05.021_b0120","doi-asserted-by":"crossref","first-page":"1097.e1","DOI":"10.1016\/j.cmi.2015.08.006","article-title":"A validation of the Danish microbiology database (MiBa) and incidence rate of Actinotignum schaalii (Actinobaculum schaalii) bacteraemia in Denmark","volume":"21","author":"Bank","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2024.05.021_b0125","doi-asserted-by":"crossref","unstructured":"Grove Krause T, Jakobsen S, Haarh M, M\u00f8lbak K. The Danish vaccination register. Eurosurveillance 2012;17:2. DOI: 10.2807\/ese.17.17.20155-en.","DOI":"10.2807\/ese.17.17.20155-en"},{"key":"10.1016\/j.vaccine.2024.05.021_b0130","first-page":"2225","article-title":"Det episke sundhedsv\u00e6sen","volume":"179","author":"Landex","year":"2017","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.vaccine.2024.05.021_b0135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jphys.2016.05.008","article-title":"Charlson Comorbidities Index","volume":"62","author":"Roffman","year":"2016","journal-title":"J Physiother"},{"key":"10.1016\/j.vaccine.2024.05.021_b0140","unstructured":"Statens Serum Institut. Covid-19 \u2013 infektioner efter vaccination og vaccineeffektivitet - uge 44. 2021."},{"key":"10.1016\/j.vaccine.2024.05.021_b0145","unstructured":"Statens Serum Institut. Vaccinations- og revaccinationsvejledninger. Stantens Serum Institut n.d. https:\/\/www.ssi.dk\/vaccinationer\/risikogrupper\/invasiv-pneumokoksygdom\/vacciations-og-revaccinationsvejledninger (accessed May 14, 2023)."},{"key":"10.1016\/j.vaccine.2024.05.021_b0150","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/jamaoto.2019.3751","article-title":"Association of Immunosuppression with Outcomes of Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck","volume":"146","author":"Tam","year":"2020","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.vaccine.2024.05.021_b0155","doi-asserted-by":"crossref","unstructured":"Pedrazzoli P, Lasagna A, Cassaniti I, Piralla A, Squeri A, Bruno R, et al. Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM). ESMO Open 2023;8. DOI: 10.1016\/j.esmoop.2023.101215.","DOI":"10.1016\/j.esmoop.2023.101215"},{"key":"10.1016\/j.vaccine.2024.05.021_b0160","unstructured":"Sundhedsstyrelsen. Skal jeg vaccineres? 2022. https:\/\/www.sst.dk\/-\/media\/Udgivelser\/2022\/Vaccination\/Efteraar\/Pjece-skal-jeg-vaccineres.ashx (accessed May 28, 2023)."},{"key":"10.1016\/j.vaccine.2024.05.021_b0165","unstructured":"Valentiner-branth P, Lomholt FK, Slotved H, Fuursted K, Dalby T, Valentiner-branth P. Rapport om pneumokokvaccination af risikogrupper med forh\u00f8jet risiko for invasiv pneumokoksygdom n.d.:1\u201310."},{"key":"10.1016\/j.vaccine.2024.05.021_b0170","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejca.2023.02.001","article-title":"Uptake of COVID-19 vaccination in people with blood cancer: Population-level cohort study of 12 million patients in England","volume":"183","author":"Hirst","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.vaccine.2024.05.021_b0175","unstructured":"Sundhedsstyrelsen. Udrulning af vaccinationer mod covid- 19 , influenza og pneumokok sygdom. 15-03-2023 n.d.:19\u201321. https:\/\/www.sst.dk\/da\/udgivelser\/2023\/Udrulning-af-vaccinationer-mod-covid-19-influenza-og-pneumokoksygdom (accessed April 4, 2023)."},{"key":"10.1016\/j.vaccine.2024.05.021_b0180","unstructured":"Gamerdinger, A., Lantz, M., & Just SN. Evaluering af Sundhedsstyrelsens borgerrettede coronakommunikation Tre analytiske nedslag. 2022."},{"key":"10.1016\/j.vaccine.2024.05.021_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fped.2022.869893","article-title":"Social Media Interventions Strengthened COVID-19 Immunization Campaign","volume":"10","author":"Di Mauro","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.vaccine.2024.05.021_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2022-066365","article-title":"Evaluating the impact of a linguistically and culturally tailored social media ad campaign on COVID-19 vaccine uptake among indigenous populations in Guatemala: a pre\/post design intervention study","volume":"12","author":"Abascal Miguel","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2024.05.021_b0200","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3322\/canjclin.11.2.42","article-title":"Clinical Staging System for Cancer and End Results Reporting","volume":"11","author":"Copeland","year":"1961","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.vaccine.2024.05.021_b0205","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/bjc.1993.140","article-title":"Performance status assessment in cancer patients. an inter-observer variability study","volume":"67","author":"S\u00f8rensen","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2024.05.021_b0210","doi-asserted-by":"crossref","unstructured":"Lins LS da S, Bezerra NVF, Freire AR, de Almeida L de FD, de Lucena EHG, Cavalcanti YW. Socio-demographic characteristics are related to the advanced clinical stage of oral cancer. Med Oral Patol Oral Cir Bucal 2019;24:e759\u201363. DOI: 10.4317\/medoral.23105.","DOI":"10.4317\/medoral.23105"},{"key":"10.1016\/j.vaccine.2024.05.021_b0215","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/TCRM.S1458","article-title":"Factors affecting therapeutic compliance: A review from the patient\u2019s perspective","volume":"4","author":"Lin","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.vaccine.2024.05.021_b0225","unstructured":"Vallentiner-Branth P, Sv\u00e6rke J\u00f8rgensen C, Kristensen Lomholt F, Slotved H-C, Fuursted K, Dalby T. Pneumokokvaccination uden for b\u00f8rnevaccinationsprogrammet i Danmark. 2020."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T06:07:46Z","timestamp":1723788466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24005668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":43,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0264410X24005668"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in vaccination uptake against pneumococcal disease, influenza, and coronavirus disease 2019 (COVID-19) before and after a Head and Neck cancer diagnosis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"125972"}}